Dactinomycin or Actinomycin-D, is an intergral part of many chemotherapeutic protocols for Paediatric tumours. Its proven efficacy and good tolerability make it a trustworthy anti cancer drug for Paediatric Oncologists. Indications: As a part of a combination chemotherapy andor multi-modality treatment regimen, for the treatment of Wilms' tumor, childhood rhabdomyosarcoma, Ewing's sarcoma and metastatic, nonseminomatous testicular cancer